Prise de decision en matière d'hormonothérapie de remplacement: Essai clinique randomisé

Canadian Family Physician

Volumn 47, Issue AUG., 2001, Pages 1586-1593

  Dodin, Sylvie ^a   Légaré, France ^b   Daudelin, Ghislaine ^b   Tetroe, Jacqueline ^b   O'Connor, Annette ^b  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ANXIETY; ARTICLE; ATTITUDE TO HEALTH; BOOK; CANADA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; ESTROGEN THERAPY; FEMALE; HUMAN; METHODOLOGY; MIDDLE AGED; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RECORDING;

ADULT; AGED; ANALYSIS OF VARIANCE; ANXIETY; DECISION MAKING; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MANUALS; MIDDLE AGED; PATIENT EDUCATION; QUEBEC; TAPE RECORDING;

EID: 0042913453     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Feig DS. Prévention des fractures ostéoporotiques chez la femme au moyen de l'oestrogénothérapie substitutive. Dans: Groupe d'étude canadien sur l'examen médical périodique. Guide canadien áe médecin? clinique préventive. Ottawa, Ont: Ministre des approvisionnements et Services Canada; 1994.
2. Conseil consultatif de pharmacologie. L'hormonothérapie de remplacement à la ménopause: guide pratique. Québec, Qué: Gouvernement du Québec; 1996.
3. Conférence canadienne de consensus sur la ménopause et l'ostéoporose. Déclaration de principe de la Société d'obstétrioue et de gynécologie canadienne. J SOGC 1998;20(13):1243-72.
4. Connelly MT, Ferrrari N, Hagen N, Inui TS. Patient-identified needs for hormone replacement therapy counseling: a qualitative study. Ann Intern Med 1999;131:265-8.
5. Lydakis C, Kerr H, Hutchings K, Lip G. Women's awareness of, and attitudes toward hormone replacement therapy: ethnic differences and effects of age and education. Int J Clin Pract 1998;51(2):7-12.
6. Hulley S, Grady D, Bush T, Furberg K, Herrington D, Riggs B, et al, for the Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-13.
7. Coulter A. Paternalism or partnership? BMJ 1999;319:719-20.
8. The North American Menopause Society. Achieving long-term continuance of menopausal ERT/HFT: consensus opinion of the North American Menopause Society. Menopause 1998;5:69-76.
9. O'Connor AM, Drake ER, Fiset V, Graham ID, Laupacis A, Tugwell P. The Ottawa patient decision aids. Eff Clin Pract 1999;2(4):163-70.
10. O'Connor A, Tugwell P, Elmslie T, Wells G, Jolly E, McPherson R, et al. Making choices: hormones after menopause. A decision aid for women. Ottawa, Ont: Université d'Ottawa; 1996.
11. O'Connor AM, Tugwell P, Wells GA, Elmslie T, Jolly E, Hollingworth E, et al. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ 1998;33(3):267-79.
12. Grady D, Ruby SM, Petitti D, Fox CS, Black D, Ettinger B, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117(12):1016-37.
13. Lock M. Menopause in cultural context. Exp Gerontol 1994;29:307-17.
14. Bellerose C, Lavallée C, Chénard L, Levasseur M. Santé Québec: et la santé, ça va? Rapport de l'enquête sociale et de santé 1992-1993. Québec, Qué: Ministère de la Santé et les Services sociaux, Gouvernement du Québec; 1995.
15. Legaré F, Godin G, Guilbert E, Laperrière L, Dodin S. Determinants of the intention to adopt hormone replacement therapy among premenopausal women. Maturitas. 2000;34(3):211-8.
16. Hawker GA, Wright JG, Coyte PC, Williams JL, Harvey B, Glazier R, et al. Differences between men and women in the rate of use of hip and knee arthroplasty.N Engl J Med 2000;342:1026-2.